feedburner

Enter your email address:

Delivered by FeedBurner

Covid-19 treatment: Cipla, Hetero Lab get nod to manufacture and sell Remdesivir

Cipla, Hetero, and Jubilant Lifesciences have signed voluntary
licensing agreements with Gilead.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cipla-hetero-get-nod-to-sell-remdesivir/articleshow/75958389.cms



0 comments:

Post a Comment